마크 월버그가 다시 헬스장 사업에 뛰어들었습니다. 이번엔 '냉탕·혈액검사·단백질 머핀'을 트러스트 펀드 없이 누구나 누릴 수 있게 만들겠다는 저가형 컨셉입니다. 롱제비티 산업이 '부유층 전용'이라는 비판을 받아온 지 오래인데, 그 문턱을 낮추겠다는 시도 자체는 반갑습니다. 건강 관리의 접근성 문제는 헬스장만의…
Slide Presentation: STS, Euroscore, and the Need for a Frailty Index for CHIP Cases
Call for Applications: MOVE-ComCashew e-MOVE 2026 (Up To €2,000 in Funding) Call for Applications: LSETF x Canva Free Business Training for 5,000 Entrepreneurs Call for Applications: Agribusiness Growth Challenge 2026 ( Up To €6,000 Award) World Bank Launches Digital Strategy to Help Small Businesses Grow and…
Loyal, a San Francisco biotech company, is developing LOY-002, a once-daily tablet for dogs 10 and older who weigh at least 14 pounds. The company has already cleared two of the three major technical sections the FDA requires before it can grant…
Your immune cells are key to your health. They fight disease and repair tissue. And they’re the youngest they’ll ever be right now. Now, you can store them for the future, just by doing a simple blood draw, thanks to…
Shillong, Oct 10: The Deputy Commissioner of West Khasi Hills has urged school students, college students, researchers, grassroots innovators and members of the public to participate in the nationwide ‘D.E.S.I.G.N. for the BioE3 Challenge’, launched by the central government’s Department of Biotechnology.
Hello. In this article, I will provide a comprehensive explanation of "cellular reprogramming (initialization/rejuvenation technology)," which has been shaking the biotechnology world in recent years, covering everything from its molecular biological mechanisms to the realistic technical bottlenecks toward practical…
Verifying posts claiming Professor Sinclair has begun the "first human rejuvenation experiment," we found that Life Biosciences, a company he founded, initiated Phase 1 trials for optic nerve disease and raised $80 million in April 2026. Here are three strategic actions. A Japanese…
With thanks to MuseCell Innovations, sponsor of the Longevity Biotech Report. Speed is the one thing in drug development that money cannot easily buy. Chinese biopharma companies, according to our Longevity Biotech Report, can move a drug through clinical trials…
GlobeNewswire 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN, âRepligenâ, or the âCompanyâ), a life sciences company focused on bioprocessing technology leadership, today announced it has completed the previously announced acquisition of BioLife Solutions, Inc (NASDAQ: BLFS, âBioLifeâ), a…
Companies and trials aiming to slow or reverse aging: Altos Labs, Retro Biosciences, NewLimit, Loyal's dog longevity drug, rejuvenation and senolytic trials.
An article joins this feed when it matches these terms. Each one is also a search of its own.